Bakker H, Schoenmakers P S, Koeleman C A, Joziasse D H, van Die I, van den Eijnden D H
Department of Medical Chemistry, Vrije Universiteit, Amsterdam, The Netherlands.
Glycobiology. 1997 Jun;7(4):539-48. doi: 10.1093/glycob/7.4.539.
UDP-GlcNAc:GlcNAc beta-R beta 1-->4-N-acetylglucosaminyltransferase (beta 4-GlcNAcT) of the snail Lymnaea stagnalis is an enzyme with structural resemblance to mammalian beta 4-galactosyltransferases (beta 4-GalT). The enzyme, which is present in the prostate gland of the snail, was expressed in a recombinant form in insect cells using the baculovirus technology. This form was used to determine the enzyme's in vitro substrate specificity in order to assess its possible role in vivo. The enzyme appeared to be a genuine GlcNAcT as no UDP-sugar other than UDP-GlcNAc could serve as an efficient donor substrate. Acceptor specificity studies showed that the enzyme is far more restricted in acceptor usage than beta 4-GalT. Oligomers of beta 4-GlcNAc were relatively poor acceptors, indicating that this enzyme is not involved in the synthesis of chitin-like molecules. Both its polypeptide structure and acceptor specificity suggest that it neither is implicated in the synthesis of the chitobiose core of N-linked glycans. Preferred substrates are those that contain a beta-GlcNAc residue attached to the carbon-6 of Gal or GalNAc residues, as found in vertebrate blood-group I-active and O-linked core 2- and 4-based oligosaccharides, respectively. By contrast, compounds in which GlcNAc is beta 6-linked to Man (as in N-linked glycans) are poor acceptors. Analysis of the products formed in vitro by 1H-NMR spectroscopy and acetolysis showed that the enzyme establishes a GlcNAc beta 1-->4GlcNAc linkage and shows branch specificity with a blood-group I-active trisaccharide substrate. Furthermore, the enzyme differs from beta 4-GalT in that it is not responsive to alpha-lactalbumin. It is proposed that the enzyme functions in a novel, variant pathway of complex-type oligosaccharide synthesis in the snail.
椎实螺(Lymnaea stagnalis)的UDP - N - 乙酰葡糖胺:β - 1,4 - N - 乙酰葡糖胺基转移酶(β4 - GlcNAcT)是一种在结构上与哺乳动物β4 - 半乳糖基转移酶(β4 - GalT)相似的酶。该酶存在于椎实螺的前列腺中,利用杆状病毒技术在昆虫细胞中以重组形式表达。这种形式用于确定该酶的体外底物特异性,以评估其在体内可能发挥的作用。该酶似乎是一种真正的GlcNAcT,因为除了UDP - GlcNAc之外,没有其他UDP - 糖可以作为有效的供体底物。受体特异性研究表明,与β4 - GalT相比,该酶在受体使用方面受到的限制要大得多。β4 - GlcNAc的寡聚体是相对较差的受体,这表明该酶不参与几丁质样分子的合成。其多肽结构和受体特异性均表明它与N - 连接聚糖的壳二糖核心合成无关。优选的底物是那些在Gal或GalNAc残基的碳 - 6上连接有β - GlcNAc残基的底物,分别见于脊椎动物血型I活性寡糖和基于O - 连接核心2和4的寡糖中。相比之下,GlcNAc以β6连接到Man的化合物(如在N - 连接聚糖中)是较差的受体。通过1H - NMR光谱和乙酰解分析体外形成的产物表明,该酶形成了GlcNAcβ1→4GlcNAc连接,并对血型I活性三糖底物表现出分支特异性。此外,该酶与β4 - GalT的不同之处在于它对α - 乳白蛋白没有反应。有人提出该酶在椎实螺复杂型寡糖合成的一条新的变异途径中发挥作用。